Risultati della ricerca - Xing‐Juan Yu
- Mostra 1 - 15 risultati su 15
-
1
GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma di Hong-Wei Sun, Xing-Juan Yu, Wenchao Wu, Jing Chen, Ming Shi, Limin Zheng, Jing Xu
Pubblicazione 2016Artigo -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma di Chaoqun Liu, Jing Xu, Zhongguo Zhou, Li-Lian Jin, Xing-Juan Yu, Gang Xiao, Jie Lin, Shi‐Mei Zhuang, Yaojun Zhang, Limin Zheng
Pubblicazione 2018Artigo -
10
-
11
EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma di Gang Xiao, Li-Lian Jin, Chaoqun Liu, Yongchun Wang, Ya-Ming Meng, Zhongguo Zhou, Jing Chen, Xing-Juan Yu, Yaojun Zhang, Jing Xu, Limin Zheng
Pubblicazione 2019Artigo -
12
Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer di Jing Chen, Hong-Wei Sun, Yanyan Yang, Haitian Chen, Xing-Juan Yu, Wenchao Wu, Yi-Tuo Xu, Li-Lian Jin, Xiaojun Wu, Jing Xu, Limin Zheng
Pubblicazione 2021Artigo -
13
-
14
-
15
Strumenti per la ricerca:
Soggetti correlati
Medicine
Biology
Cancer research
Internal medicine
Hepatocellular carcinoma
Immunology
Pathology
Biochemistry
Cancer
Immune system
Immunohistochemistry
Oncology
Gene
Immunotherapy
Amino acid
CD68
CD8
Cancer immunotherapy
Carcinoma
Cell biology
China
Confidence interval
Downregulation and upregulation
Genetics
Glutamine
Hazard ratio
Myeloid
Nasopharyngeal carcinoma
Proportional hazards model
Radiation therapy